| Dr Jack Mccallion, MD | |
|
2014 Washington St, Newton, MA 02462-1607 | |
| (617) 243-6298 | |
| (617) 243-6184 |
| Full Name | Dr Jack Mccallion |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 37 Years |
| Location | 2014 Washington St, Newton, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083695274 | NPI | - | NPPES |
| J07425 | Other | MA | BCBS MA |
| 059984 | Other | MA | TUFTS HEALTH PLAN |
| 3035522 | Medicaid | MA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 59984 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sacred Heart Hospital On The Emerald Coast | Miramar beach, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ams Anesthetist Services Llc | 8325298458 | 144 |
News Archive
National Community Pharmacists Association (NCPA) Executive Vice President and CEO Kathleen Jaeger issued the following statement today in response to the Avalere Health study analyzing how the formulary and cost-sharing benefits changes made by various Medicare Part D prescription drug plans affect seniors:
Survivorship care plans are an important tool to help cancer survivors transition out of active treatment and back to their regular lives, but a new study found that a number of vulnerable groups are not receiving those plans.
ViroPharma Incorporated today announced that it has initiated an open-label, multi-dose Phase 2 study to evaluate the safety, and pharmacokinetics and pharmacodynamics of subcutaneous versus intravenous administration of Cinryze (C1 esterase inhibitor [human)] in 24 adolescents and adult subjects with hereditary angioedema.
Japanese researchers have found a piece of the "missing link" about how bone marrow stromal cells restore lost neurologic function when transplanted into animals exhibiting central nervous system disorders, according to a study in the March issue of the Journal of Nuclear Medicine.
› Verified 6 days ago
| Entity Name | Ams Anesthetist Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770834426 PECOS PAC ID: 8325298458 Enrollment ID: O20121025000224 |
News Archive
National Community Pharmacists Association (NCPA) Executive Vice President and CEO Kathleen Jaeger issued the following statement today in response to the Avalere Health study analyzing how the formulary and cost-sharing benefits changes made by various Medicare Part D prescription drug plans affect seniors:
Survivorship care plans are an important tool to help cancer survivors transition out of active treatment and back to their regular lives, but a new study found that a number of vulnerable groups are not receiving those plans.
ViroPharma Incorporated today announced that it has initiated an open-label, multi-dose Phase 2 study to evaluate the safety, and pharmacokinetics and pharmacodynamics of subcutaneous versus intravenous administration of Cinryze (C1 esterase inhibitor [human)] in 24 adolescents and adult subjects with hereditary angioedema.
Japanese researchers have found a piece of the "missing link" about how bone marrow stromal cells restore lost neurologic function when transplanted into animals exhibiting central nervous system disorders, according to a study in the March issue of the Journal of Nuclear Medicine.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jack Mccallion, MD 2014 Washington St, Newton, MA 02462-1607 Ph: (617) 243-6298 | Dr Jack Mccallion, MD 2014 Washington St, Newton, MA 02462-1607 Ph: (617) 243-6298 |
News Archive
National Community Pharmacists Association (NCPA) Executive Vice President and CEO Kathleen Jaeger issued the following statement today in response to the Avalere Health study analyzing how the formulary and cost-sharing benefits changes made by various Medicare Part D prescription drug plans affect seniors:
Survivorship care plans are an important tool to help cancer survivors transition out of active treatment and back to their regular lives, but a new study found that a number of vulnerable groups are not receiving those plans.
ViroPharma Incorporated today announced that it has initiated an open-label, multi-dose Phase 2 study to evaluate the safety, and pharmacokinetics and pharmacodynamics of subcutaneous versus intravenous administration of Cinryze (C1 esterase inhibitor [human)] in 24 adolescents and adult subjects with hereditary angioedema.
Japanese researchers have found a piece of the "missing link" about how bone marrow stromal cells restore lost neurologic function when transplanted into animals exhibiting central nervous system disorders, according to a study in the March issue of the Journal of Nuclear Medicine.
› Verified 6 days ago
Dr. Antje Marianne Barreveld, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2014 Washington St, Newton, MA 02462 Phone: 617-243-6298 | |
Viet Lukasz Cai, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2014 Washington St, Newton, MA 02462 Phone: 617-243-6467 | |
Michelle Qi, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2014 Washington St, Newton, MA 02462 Phone: 617-243-6298 | |
Kenneth Aaron Garrett, DO Anesthesiology Medicare: Medicare Enrolled Practice Location: 2014 Washington St, Newton, MA 02462 Phone: 617-243-6298 | |
Davies G Agyekum, M.D., PHD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2014 Washington St, Newton, MA 02462 Phone: 617-243-6298 | |
Jaime T Lopez, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 2014 Washington St, Dept Of Anesthesia, Newton, MA 02462 Phone: 617-243-6298 Fax: 617-243-6184 |